Blue Goose Capital
Blue Goose Capital is a venture capital firm founded in 2018 and located in Cambridge, Massachusetts. The firm focuses on investing in the healthcare sector, specifically targeting biopharmaceutical, data, and medical device companies. Blue Goose Capital initiates its investments with seed capital and is currently managing its second fund, which exclusively invests in U.S. biotechnology firms beginning at the Series A stage. The firm aims to support innovative solutions within the healthcare industry.
Top Stages
1 past transactions
AtG Therapeutics
Seed Round in 2022
AtG Therapeutics is a Barcelona-based biotechnology company spun off from IDIBELL and ICO. It focuses on developing innovative drug classes and biomarkers aimed at preventing cancer therapeutic resistance. The company's mission is to discover and advance new therapeutic technologies, including biomarkers, drugs, and novel mechanisms, enabling healthcare professionals to enhance the lives of patients affected by cancer therapeutic resistance.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.